Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling
View ORCID ProfileC Manisty, TA Treibel, M Jensen, A Semper, G Joy, View ORCID ProfileRK Gupta, T Cutino-Moguel, M Andiapen, J Jones, S Taylor, A Otter, C Pade, JM Gibbons, WYJ Lee, M Jones, D Williams, J Lambourne, M Fontana, DM Altmann, RJ Boyton, MK Maini, A McKnight, T Brooks, B Chain, M Noursadeghi, JC Moon on behalf of COVIDsortium Investigators
doi: https://doi.org/10.1101/2020.11.04.20225920
C Manisty
1Institute of Cardiovascular Sciences, University College London, London, UK
2Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK, London, UK
TA Treibel
1Institute of Cardiovascular Sciences, University College London, London, UK
2Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK, London, UK
M Jensen
2Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK, London, UK
A Semper
3National Infection Service, Public Health England, Porton Down, UK
G Joy
2Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK, London, UK
RK Gupta
4Division of Infection and Immunity, University College London, London, UK
T Cutino-Moguel
5Department of Virology, Barts Health NHS Trust, London, UK
M Andiapen
6Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK
J Jones
3National Infection Service, Public Health England, Porton Down, UK
S Taylor
3National Infection Service, Public Health England, Porton Down, UK
A Otter
3National Infection Service, Public Health England, Porton Down, UK
C Pade
7Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
JM Gibbons
7Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
WYJ Lee
7Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
M Jones
8Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and 24 Dentistry, Queen Mary University of London, London, UK
D Williams
9MRC Unit for Lifelong Health and Ageing, University College London, London, UK
10Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
J Lambourne
11Department of Infection, Barts Health NHS Trust, London, UK
M Fontana
12Royal Free London NHS Foundation Trust, London, UK
13Division of Medicine, University College London, London, UK
DM Altmann
14Department of Immunology and Inflammation, Imperial College London, London, UK
RJ Boyton
15Department of Infectious Disease, Imperial College London, London, UK
MK Maini
4Division of Infection and Immunity, University College London, London, UK
A McKnight
8Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and 24 Dentistry, Queen Mary University of London, London, UK
T Brooks
3National Infection Service, Public Health England, Porton Down, UK
B Chain
4Division of Infection and Immunity, University College London, London, UK
M Noursadeghi
4Division of Infection and Immunity, University College London, London, UK
JC Moon
1Institute of Cardiovascular Sciences, University College London, London, UK
2Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK, London, UK
Article usage
Posted November 06, 2020.
Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling
C Manisty, TA Treibel, M Jensen, A Semper, G Joy, RK Gupta, T Cutino-Moguel, M Andiapen, J Jones, S Taylor, A Otter, C Pade, JM Gibbons, WYJ Lee, M Jones, D Williams, J Lambourne, M Fontana, DM Altmann, RJ Boyton, MK Maini, A McKnight, T Brooks, B Chain, M Noursadeghi, JC Moon
medRxiv 2020.11.04.20225920; doi: https://doi.org/10.1101/2020.11.04.20225920
Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling
C Manisty, TA Treibel, M Jensen, A Semper, G Joy, RK Gupta, T Cutino-Moguel, M Andiapen, J Jones, S Taylor, A Otter, C Pade, JM Gibbons, WYJ Lee, M Jones, D Williams, J Lambourne, M Fontana, DM Altmann, RJ Boyton, MK Maini, A McKnight, T Brooks, B Chain, M Noursadeghi, JC Moon
medRxiv 2020.11.04.20225920; doi: https://doi.org/10.1101/2020.11.04.20225920
Subject Area
Subject Areas
- Addiction Medicine (350)
- Allergy and Immunology (674)
- Anesthesia (181)
- Cardiovascular Medicine (2666)
- Dermatology (225)
- Emergency Medicine (404)
- Epidemiology (12278)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4132)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2677)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (400)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3920)
- Nursing (212)
- Nutrition (583)
- Oncology (2056)
- Ophthalmology (591)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1121)
- Primary Care Research (458)
- Public and Global Health (6556)
- Radiology and Imaging (1411)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (453)
- Toxicology (54)
- Transplantation (187)
- Urology (167)